High Dose Interleukin-2 Followed by Intermittent Low Dose Temozolomide in Patients With Melanoma
Clinical trial NCT01124734 · COMPLETED
Trial details
- NCT number
- NCT01124734
- Sponsor
- Milton S. Hershey Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2017-07-18
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.